|
|
|
|||||
|
|
|
||||
|
October 2005 In a new policy statement, Emergency Contraception, the AAP supports the availability of emergency contraception for adolescents and encourages abstinence combined with comprehensive sexual education as the best way to help prevent unintended pregnancies and sexually transmitted diseases (STDs). Emergency contraception has the potential to significantly reduce teen pregnancy rates, the Committee on Adolescence wrote in the policy. The AAP continues to support improved availability of emergency contraception to teens and young adults, including over-the-counter access and limiting the barriers to access placed by some health care providers and venues. Improving the knowledge, accessibility and availability of contraceptive services may help to reduce unplanned pregnancies among teenagers and young adults. Ensuring access to contraception with appropriate education on proper use and indications of the various methods are essential components to comprehensive sex education for sexually active teenagers and young adults. The focus of the policy statement is to provide pediatricians with information about emergency contraceptives, so that they can better inform patients about their use, the AAP statement suggested. The statement provided a review of emergency contraception, available formulations, potential adverse events, efficacy, use and contraindications. It also included adolescents and young adults reported knowledge and attitudes about access and availability to hormonal emergency contraception.
|
|
|
The policy statement noted that the two FDA-approved medications, Preven (Gynetics) and Plan B (Barr Pharmaceuticals), are safe and effective for adolescent use.
The FDA approved Preven, the combination of estrogen (ethinyl estradiol) and progestin (levonorgestrel) emergency contraception, in 1998.
A year later, the FDA approved Plan B, made of levonorgestrel. Plan B, the progestin-only method, Preven, is more effective and better tolerated than the combined hormone method, and it is the first choice of dedicated products for emergency contraception. Emergency contraception adverse events are few. Preven, effectively off the market since this past year, is gradually but completely being replaced in stock by Plan B in pharmacies.
The committee advised that patients who use emergency contraception should see their physician for identification of a more dependable contraceptive method and testing for STDs. That visit should also include the discussion of abstinence as a strategy for decreasing the risk of unwanted pregnancy and avoiding STDs.
For more information:
- For more information visit the AAPs Web site at www.aap.org.
- Committee on Adolescence. Emergency contraception. Pediatrics. 2005;116:1038-1047.
![]()